FDA环氧乙烷灭菌设施 III 类设备变更的过渡性执法政策_中英文版
VIP专享
Contains Nonbinding Recommendations
Transitional Enforcement Policy for
Ethylene Oxide Sterilization Facility
Changes for Class III Devices
Guidance for Industry and
Food and Drug Administration Staff
Document issued on November 26, 2024.
For questions about this document regarding CDRH-regulated devices, contact CDRH-ETO-
SiteChange@fda.hhs.gov.
For questions about this document regarding CBER-regulated devices, contact
ocod@fda.hhs.gov.
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Devices and Radiological Health
Center for Biologics Evaluation and Research
Contains Nonbinding Recommendations
Preface
Public Comment
You may submit electronic comments and suggestions at any time for Agency consideration to
https://www.regulations.gov. Submit written comments to the Dockets Management Staff, Food
and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD 20852-
1740. Identify all comments with the docket number FDA-2024-D-2274. Comments may not be
acted upon by the Agency until the document is next revised or updated.
Additional Copies
CDRH
Additional copies are available from the Internet. You may also send an email request to CDRH-
Guidance@fda.hhs.gov to receive a copy of the guidance. Please include the document number
GUI00007027 and complete title of the guidance in the request.
CBER
Additional copies of this guidance are available from the Office of Communication, Outreach
and Development (OCOD), 10903 New Hampshire Ave., Bldg. 71, Rm. 3128, Silver Spring,
MD 20993-0002, or by calling 1-800-835-4709 or 240-402-8010, or email ocod@fda.hhs.gov, or
from the Internet at https://www.fda.gov/vaccines-blood-biologics/guidance-compliance-
regulatory-information-biologics.
For questions on the content of this guidance, contact OCOD at the phone numbers or email
address listed above.
摘要:
展开>>
收起<<
ContainsNonbindingRecommendationsTransitionalEnforcementPolicyforEthyleneOxideSterilizationFacilityChangesforClassIIIDevicesGuidanceforIndustryandFoodandDrugAdministrationStaffDocumentissuedonNovember26,2024.ForquestionsaboutthisdocumentregardingCDRH-regulateddevices,contactCDRH-ETO-SiteChange@fda.h...
声明:如果您的权利被侵害,请联系我们的进行举报。
相关推荐
-
GB∕T 25915.2-2021 洁净室及相关受控环境 第2部分:洁净室空气粒子浓度的监测
2024-04-17 999+ -
GB∕T 25915.3-2024洁净室及相关受控环境 第3部分:检测方法VIP免费
2024-08-09 127 -
(高清)GB∕T 25915.3-2024 洁净室及相关受控环境第3部分:检测方法VIP免费
2025-08-27 999+ -
GB∕T 16886.1-2025医疗器械生物学评价 第1部分 风险管理过程中生物学安全性评价的要求和通用原则(草案稿)VIP免费
2025-09-02 833 -
GB∕T 16886.11-2021 医疗器械生物学评价 第11部分:全身毒性试验VIP免费
2025-09-02 865 -
GB∕T 191-2025 包装储运图示标志(征求意见稿)VIP免费
2025-09-29 999+ -
GB∕T 19000-2016 质量管理体系 基础和术语(高清)VIP免费
2025-10-27 999+ -
GB∕T 19001-2016 质量管理体系要求
2025-10-27 999+ -
GB∕T 16292-2025 医药工业洁净室(区)悬浮粒子的测试方法VIP免费
2025-10-29 999+ -
GB∕T 16292《医药工业洁净室(区)悬浮粒子的测试方法》2010版和2025版对比分析(逐条对比)VIP免费
2025-10-30 579
作者:薛定谔的龙猫
分类:专业资料
价格:80质量币
属性:42 页
大小:1.13MB
格式:PDF
时间:2025-11-12

